Oxford Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OXFORD PHARMS, and what generic and branded alternatives to OXFORD PHARMS drugs are available?
OXFORD PHARMS has thirty-three approved drugs.
Drugs and US Patents for Oxford Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxford Pharms | DIPYRIDAMOLE | dipyridamole | TABLET;ORAL | 040542-001 | Apr 21, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Oxford Pharms | ALPRAZOLAM | alprazolam | TABLET;ORAL | 078491-003 | Sep 25, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Oxford Pharms | ETODOLAC | etodolac | TABLET;ORAL | 074819-002 | Apr 28, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.